Published in Endocrinology on January 10, 2008
Thyroid hormone transporters--functions and clinical implications. Nat Rev Endocrinol (2015) 1.73
Essential molecular determinants for thyroid hormone transport and first structural implications for monocarboxylate transporter 8. J Biol Chem (2010) 0.97
Thyroid hormone action: astrocyte-neuron communication. Front Endocrinol (Lausanne) (2014) 0.87
Evidence for a homodimeric structure of human monocarboxylate transporter 8. Endocrinology (2009) 0.86
Insights into molecular properties of the human monocarboxylate transporter 8 by combining functional with structural information. Thyroid Res (2011) 0.86
SLC16A2 mutations in two Japanese patients with Allan-Herndon-Dudley syndrome. Hum Genome Var (2014) 0.82
Inherited defects of thyroid hormone-cell-membrane transport: review of recent findings. Curr Opin Endocrinol Diabetes Obes (2013) 0.81
Hypotonic male infant and MCT8 deficiency - a diagnosis to think about. BMC Pediatr (2014) 0.77
Structure and function of thyroid hormone plasma membrane transporters. Eur Thyroid J (2014) 0.75
Genetic disorders of thyroid metabolism and brain development. Dev Med Child Neurol (2014) 0.75
Further Insights into the Allan-Herndon-Dudley Syndrome: Clinical and Functional Characterization of a Novel MCT8 Mutation. PLoS One (2015) 0.75
Understanding the hypothalamus-pituitary-thyroid axis in mct8 deficiency. Eur Thyroid J (2012) 0.75
Inherited defects in thyroid hormone cell-membrane transport and metabolism. Best Pract Res Clin Endocrinol Metab (2013) 0.75
Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med (1999) 11.19
Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol (Oxf) (1999) 3.99
Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet (2004) 2.98
A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am J Hum Genet (2003) 2.80
Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem (2003) 2.71
The monocarboxylate transporter 8 linked to human psychomotor retardation is highly expressed in thyroid hormone-sensitive neuron populations. Endocrinology (2005) 2.14
Genetics of congenital hypothyroidism. J Med Genet (2005) 1.91
Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene. Am J Hum Genet (2005) 1.79
Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocr Rev (2001) 1.69
Thyroid hormones and brain development. Vitam Horm (2005) 1.57
Allan-Herndon syndrome. I. Clinical studies. Am J Hum Genet (1990) 1.50
Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter. Mol Endocrinol (2002) 1.49
Thyroid hormone transport by the human monocarboxylate transporter 8 and its rate-limiting role in intracellular metabolism. Mol Endocrinol (2006) 1.33
A novel transmembrane transporter encoded by the XPCT gene in Xq13.2. Hum Mol Genet (1994) 1.31
Extended clinical phenotype, endocrine investigations and functional studies of a loss-of-function mutation A150V in the thyroid hormone specific transporter MCT8. Eur J Endocrinol (2005) 1.19
Cellular entry of thyroid hormones by organic anion transporting polypeptides. Best Pract Res Clin Endocrinol Metab (2007) 1.14
Substitution of cysteine for selenocysteine in the catalytic center of type III iodothyronine deiodinase reduces catalytic efficiency and alters substrate preference. Endocrinology (2003) 1.12
Helix 8 and helix 10 are involved in substrate recognition in the rat monocarboxylate transporter MCT1. Biochemistry (1999) 1.12
X-linked MCT8 gene mutations: characterization of the pediatric neurologic phenotype. J Child Neurol (2005) 1.11
Allan-Herndon-Dudley syndrome: clinical and linkage studies on a second family. Am J Med Genet (1992) 1.10
X-linked paroxysmal dyskinesia and severe global retardation caused by defective MCT8 gene. J Neurol (2005) 1.08
Unexpected peripheral markers of thyroid function in a patient with a novel mutation of the MCT8 thyroid hormone transporter gene. Horm Res (2006) 1.00
Mechanisms of disease: psychomotor retardation and high T3 levels caused by mutations in monocarboxylate transporter 8. Nat Clin Pract Endocrinol Metab (2006) 0.99
Functional analysis of monocarboxylate transporter 8 mutations identified in patients with X-linked psychomotor retardation and elevated serum triiodothyronine. J Clin Endocrinol Metab (2007) 0.98
Thyroid hormone transport by monocarboxylate transporters. Best Pract Res Clin Endocrinol Metab (2007) 0.98
Tissue uptake of thyroid hormone by amino acid transporters. Best Pract Res Clin Endocrinol Metab (2007) 0.94
A novel mutation in the monocarboxylate transporter 8 gene in a boy with putamen lesions and low free T4 levels in cerebrospinal fluid. J Pediatr (2005) 0.94
Molecular genetic defects in congenital hypothyroidism. Eur J Endocrinol (2004) 0.93
Damaged reproduction: the most important consequence of iodine deficiency. J Clin Endocrinol Metab (2001) 0.91
Endemic cretinism: toward a unifying hypothesis. Thyroid (1993) 0.90
Decreased cellular uptake and metabolism in Allan-Herndon-Dudley syndrome (AHDS) due to a novel mutation in the MCT8 thyroid hormone transporter. J Med Genet (2005) 0.85
Thyroid hormone deiodinases in the central and peripheral nervous system. Thyroid (2005) 0.82
Inactivation and affinity-labeling of rat liver iodothyronine deiodinase with N-bromoacetyl-3,3',5-triiodothyronine. Biochem Biophys Res Commun (1984) 0.78
Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N Engl J Med (2008) 10.88
A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nat Genet (2008) 8.44
A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation. Nat Genet (2009) 8.30
High frequency of neurexin 1beta signal peptide structural variants in patients with autism. Neurosci Lett (2006) 3.64
Mediator links epigenetic silencing of neuronal gene expression with x-linked mental retardation. Mol Cell (2008) 3.53
Localized mutations in the gene encoding the cytoskeletal protein filamin A cause diverse malformations in humans. Nat Genet (2003) 3.23
Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet (2004) 2.98
Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem (2003) 2.71
Detecting polymorphisms and mutations in candidate genes. Am J Hum Genet (2002) 2.70
A recurrent mutation in MED12 leading to R961W causes Opitz-Kaveggia syndrome. Nat Genet (2007) 2.51
Mutations in UPF3B, a member of the nonsense-mediated mRNA decay complex, cause syndromic and nonsyndromic mental retardation. Nat Genet (2007) 2.35
Thyroid hormone concentrations, disease, physical function, and mortality in elderly men. J Clin Endocrinol Metab (2005) 2.35
X chromosome-inactivation patterns of 1,005 phenotypically unaffected females. Am J Hum Genet (2006) 2.33
A method for rapid, targeted CNV genotyping identifies rare variants associated with neurocognitive disease. Genome Res (2009) 2.29
Localisation and mechanism of renal retention of radiolabelled somatostatin analogues. Eur J Nucl Med Mol Imaging (2005) 2.26
The monocarboxylate transporter 8 linked to human psychomotor retardation is highly expressed in thyroid hormone-sensitive neuron populations. Endocrinology (2005) 2.14
XLMR genes: update 2007. Eur J Hum Genet (2008) 2.07
Mutations in CUL4B, which encodes a ubiquitin E3 ligase subunit, cause an X-linked mental retardation syndrome associated with aggressive outbursts, seizures, relative macrocephaly, central obesity, hypogonadism, pes cavus, and tremor. Am J Hum Genet (2007) 2.07
Hypothalamic thyroid hormone catabolism acts as a gatekeeper for the seasonal control of body weight and reproduction. Endocrinology (2007) 2.06
Mutations in the iodotyrosine deiodinase gene and hypothyroidism. N Engl J Med (2008) 2.06
Recurrent infections, hypotonia, and mental retardation caused by duplication of MECP2 and adjacent region in Xq28. Pediatrics (2006) 2.03
The original Lujan syndrome family has a novel missense mutation (p.N1007S) in the MED12 gene. J Med Genet (2007) 2.02
Iodothyronine levels in the human developing brain: major regulatory roles of iodothyronine deiodinases in different areas. J Clin Endocrinol Metab (2004) 1.95
Maternal thyroid function during early pregnancy and cognitive functioning in early childhood: the generation R study. J Clin Endocrinol Metab (2010) 1.93
In vitro profiling of the endocrine-disrupting potency of brominated flame retardants. Toxicol Sci (2006) 1.87
Mutations in the small GTPase gene RAB39B are responsible for X-linked mental retardation associated with autism, epilepsy, and macrocephaly. Am J Hum Genet (2010) 1.87
Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects. J Clin Endocrinol Metab (2003) 1.86
Mutations in the gene encoding the Sigma 2 subunit of the adaptor protein 1 complex, AP1S2, cause X-linked mental retardation. Am J Hum Genet (2006) 1.85
Nonrecurrent MECP2 duplications mediated by genomic architecture-driven DNA breaks and break-induced replication repair. Genome Res (2008) 1.81
Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8. J Clin Invest (2007) 1.80
Submicroscopic duplications of the hydroxysteroid dehydrogenase HSD17B10 and the E3 ubiquitin ligase HUWE1 are associated with mental retardation. Am J Hum Genet (2008) 1.80
Neurexin 1alpha structural variants associated with autism. Neurosci Lett (2008) 1.80
Branchio-oto-renal syndrome: the mutation spectrum in EYA1 and its phenotypic consequences. Hum Mutat (2004) 1.77
Disruption at the PTCHD1 Locus on Xp22.11 in Autism spectrum disorder and intellectual disability. Sci Transl Med (2010) 1.75
Skewed X-chromosome inactivation is a common feature of X-linked mental retardation disorders. Am J Hum Genet (2002) 1.74
Mutations in ZDHHC9, which encodes a palmitoyltransferase of NRAS and HRAS, cause X-linked mental retardation associated with a Marfanoid habitus. Am J Hum Genet (2007) 1.73
Sorafenib-induced hypothyroidism is associated with increased type 3 deiodination. J Clin Endocrinol Metab (2010) 1.72
Minireview: thyroid hormone transporters: the knowns and the unknowns. Mol Endocrinol (2010) 1.67
Coding exons function as tissue-specific enhancers of nearby genes. Genome Res (2012) 1.64
Endocrine effects of tetrabromobisphenol-A (TBBPA) in Wistar rats as tested in a one-generation reproduction study and a subacute toxicity study. Toxicology (2007) 1.63
Maternal thyroid autoimmunity during pregnancy and the risk of attention deficit/hyperactivity problems in children: the Generation R Study. Thyroid (2011) 1.61
Identification of DIO2 as a new susceptibility locus for symptomatic osteoarthritis. Hum Mol Genet (2008) 1.60
Fine-scale survey of X chromosome copy number variants and indels underlying intellectual disability. Am J Hum Genet (2010) 1.60
Mutations in the guanine nucleotide exchange factor gene IQSEC2 cause nonsyndromic intellectual disability. Nat Genet (2010) 1.52
Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J Clin Endocrinol Metab (2003) 1.50
Fragile X and X-linked intellectual disability: four decades of discovery. Am J Hum Genet (2012) 1.50
A 28-day oral dose toxicity study in Wistar rats enhanced to detect endocrine effects of decabromodiphenyl ether (decaBDE). Toxicol Lett (2008) 1.48
Developmental and cell-specific expression of thyroid hormone transporters in the mouse cochlea. Endocrinology (2011) 1.47
Blood pressure and neurohormonal responses to renal nerve ablation in treatment-resistant hypertension. J Hypertens (2014) 1.47
X-linked spermine synthase gene (SMS) defect: the first polyamine deficiency syndrome. Eur J Hum Genet (2003) 1.45
Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10. Mol Endocrinol (2008) 1.44
Clinical phenotype and mutant TRα1. N Engl J Med (2012) 1.43
Hypoxia-inducible factor induces local thyroid hormone inactivation during hypoxic-ischemic disease in rats. J Clin Invest (2008) 1.43
Soluble Flt1 and placental growth factor are novel determinants of newborn thyroid (dys)function: the generation R study. J Clin Endocrinol Metab (2014) 1.40
High-normal thyroid function and risk of atrial fibrillation: the Rotterdam study. Arch Intern Med (2008) 1.39
Serum 3,3',5'-triiodothyronine (rT3) and 3,5,3'-triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. J Clin Endocrinol Metab (2005) 1.37
Prevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders. Eur J Hum Genet (2012) 1.36
Optimising conditions for radiolabelling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities. Eur J Nucl Med Mol Imaging (2003) 1.34
AGTR2 mutations in X-linked mental retardation. Science (2002) 1.34
Thyroid hormone transport by the human monocarboxylate transporter 8 and its rate-limiting role in intracellular metabolism. Mol Endocrinol (2006) 1.33
A unique exonic splice enhancer mutation in a family with X-linked mental retardation and epilepsy points to a novel role of the renin receptor. Hum Mol Genet (2005) 1.32
Thyroid hormone transport in and out of cells. Trends Endocrinol Metab (2008) 1.32
A genomic rearrangement resulting in a tandem duplication is associated with split hand-split foot malformation 3 (SHFM3) at 10q24. Hum Mol Genet (2003) 1.32
Computational analysis of missense mutations causing Snyder-Robinson syndrome. Hum Mutat (2010) 1.31
The reduced expression of the HADH2 protein causes X-linked mental retardation, choreoathetosis, and abnormal behavior. Am J Hum Genet (2006) 1.27
X-linked mental retardation with seizures and carrier manifestations is caused by a mutation in the creatine-transporter gene (SLC6A8) located in Xq28. Am J Hum Genet (2002) 1.27
Maternal thyroid function during pregnancy and behavioral problems in the offspring: the generation R study. Pediatr Res (2011) 1.27
Induction of thyroid hormone-degrading deiodinase in cardiac hypertrophy and failure. Endocrinology (2002) 1.25
Genetics and phenomics of thyroid hormone transport by MCT8. Mol Cell Endocrinol (2010) 1.25
Minireview: Pathophysiological importance of thyroid hormone transporters. Endocrinology (2009) 1.25
Effects of serum TSH and FT4 levels and the TSHR-Asp727Glu polymorphism on bone: the Rotterdam Study. Clin Endocrinol (Oxf) (2007) 1.25
Biotransformation of brominated flame retardants into potentially endocrine-disrupting metabolites, with special attention to 2,2',4,4'-tetrabromodiphenyl ether (BDE-47). Mol Nutr Food Res (2008) 1.23
Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients. Clin Endocrinol (Oxf) (2007) 1.22
A mutation affecting the sodium/proton exchanger, SLC9A6, causes mental retardation with tau deposition. Brain (2010) 1.20
Identification and functional characterization of zebrafish solute carrier Slc16a2 (Mct8) as a thyroid hormone membrane transporter. Endocrinology (2011) 1.20
A phytoestrogen-rich diet increases energy expenditure and decreases adiposity in mice. Environ Health Perspect (2007) 1.19
Potent inhibition of estrogen sulfotransferase by hydroxylated metabolites of polyhalogenated aromatic hydrocarbons reveals alternative mechanism for estrogenic activity of endocrine disrupters. J Clin Endocrinol Metab (2002) 1.16
Further evidence that the rs1858830 C variant in the promoter region of the MET gene is associated with autistic disorder. Autism Res (2009) 1.16
A role of the (pro)renin receptor in neuronal cell differentiation. Am J Physiol Regul Integr Comp Physiol (2009) 1.16
An X-linked channelopathy with cardiomegaly due to a CLIC2 mutation enhancing ryanodine receptor channel activity. Hum Mol Genet (2012) 1.16
A common variation in deiodinase 1 gene DIO1 is associated with the relative levels of free thyroxine and triiodothyronine. J Clin Endocrinol Metab (2008) 1.15
Genetic variation in thyroid hormone pathway genes; polymorphisms in the TSH receptor and the iodothyronine deiodinases. Eur J Endocrinol (2006) 1.14
Physiological thyroid hormone levels regulate numerous skeletal muscle transcripts. J Clin Endocrinol Metab (2009) 1.14
Analysis of the neuroligin 4Y gene in patients with autism. Psychiatr Genet (2008) 1.14
Consequences of monocarboxylate transporter 8 deficiency for renal transport and metabolism of thyroid hormones in mice. Endocrinology (2009) 1.13
Thyroid hormone transporters. Vitam Horm (2005) 1.13
A missense mutation in CASK causes FG syndrome in an Italian family. Am J Hum Genet (2009) 1.12
Substitution of cysteine for selenocysteine in the catalytic center of type III iodothyronine deiodinase reduces catalytic efficiency and alters substrate preference. Endocrinology (2003) 1.12
Fragile X syndrome detection in newborns-pilot study. Genet Med (2008) 1.12
Large induction of type III deiodinase expression after partial hepatectomy in the regenerating mouse and rat liver. Endocrinology (2008) 1.12
A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function. PLoS Genet (2013) 1.12
X-linked MCT8 gene mutations: characterization of the pediatric neurologic phenotype. J Child Neurol (2005) 1.11
Clinical variation of Aarskog syndrome in a large family with 2189delA in the FGD1 gene. Am J Med Genet A (2006) 1.11